Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Arq
ARQ
$86.3M
| $1.3M | ﹤0.01% |
267,957
+9,654
| +4% | +$55.6K |
|
3052
Esquire Financial Holdings
ESQ
$1.13B
| $1.3M | ﹤0.01% |
76,705
+776
| +1% | +$12.3K |
|
3053
Xeris Biopharma Holdings
XERS
$1.39B
| $1.29M | ﹤0.01% |
485,086
-3,850
| -0.8% | -$13.4K |
|
|
ENZ
3054
DELISTED
Enzo Biochem, Inc.
ENZ
| $1.29M | ﹤0.01% |
575,005
+15,262
| +3% | +$39.2K |
|
|
MLVF
3055
DELISTED
Malvern Bancorp, Inc.
MLVF
| $1.28M | ﹤0.01% |
101,012
-40,649
| -29% | -$480K |
|
|
LKFT
3056
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.75B
| $1.28M | ﹤0.01% |
6,503
-488
| -7% | -$101K |
|
|
RYZ
3057
Ryerson Holding Corp
RYZ
$1.47B
| $1.28M | ﹤0.01% |
227,207
-9,170
| -4% | -$45.4K |
|
3058
Silvercrest Asset Management
SAMG
$79.9M
| $1.28M | ﹤0.01% |
100,484
+20,873
| +26% | +$222K |
|
|
GTM
3059
ZoomInfo Technologies
GTM
$1.05B
| $1.27M | ﹤0.01% |
+24,847
| New | +$1.19M |
|
|
AGS
3060
DELISTED
PlayAGS
AGS
| $1.26M | ﹤0.01% |
372,882
+1,246
| +0.3% | +$4.77K |
|
3061
Willis Lease Finance
WLFC
$1.76B
| $1.26M | ﹤0.01% |
155,550
+5,373
| +4% | +$38.3K |
|
|
ATXI
3062
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
| $1.26M | ﹤0.01% |
104
+42
| +68% | +$474K |
|
3063
Global Water Resources
GWRS
$210M
| $1.26M | ﹤0.01% |
119,352
+13,291
| +13% | +$140K |
|
3064
RELX
RELX
$62.8B
| $1.26M | ﹤0.01% |
53,313
-25,584
| -32% | -$585K |
|
3065
Fennec Pharmaceuticals
FENC
$331M
| $1.25M | ﹤0.01% |
+150,200
| New | +$1.12M |
|
3066
Radware
RDWR
$1.15B
| $1.25M | ﹤0.01% |
52,885
-5,139
| -9% | -$118K |
|
3067
South Plains Financial
SPFI
$850M
| $1.25M | ﹤0.01% |
87,484
+479
| +0.6% | +$6.25K |
|
3068
Bristow Group
VTOL
$1.35B
| $1.24M | ﹤0.01% |
89,339
-49,743
| -36% | -$531K |
|
3069
NACCO Industries
NC
$366M
| $1.24M | ﹤0.01% |
53,298
+238
| +0.4% | +$6.41K |
|
3070
Energy Fuels
UUUU
$3.01B
| $1.24M | ﹤0.01% |
825,550
+142,259
| +21% | +$226K |
|
|
MR
3071
DELISTED
Montage Resources Corporation Common Stock
MR
| $1.24M | ﹤0.01% |
313,955
+10,647
| +4% | +$54.3K |
|
3072
Asure Software
ASUR
$254M
| $1.24M | ﹤0.01% |
192,744
+96,176
| +100% | +$600K |
|
3073
Caledonia Mining Corp
CMCL
$360M
| $1.24M | ﹤0.01% |
+71,502
| New | +$995K |
|
3074
Beyond Air
XAIR
$4.53M
| $1.24M | ﹤0.01% |
426
+226
| +113% | +$697K |
|
|
SCTL
3075
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $1.23M | ﹤0.01% |
270,820
-21,367
| -7% | -$132K |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.